Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2020: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
Disease status of leukemia is judged by the type of genetic abnormalities and the degree of therapeutic effect, but there are a lot of genetic abnormalities and detecting method is not standardized. To provide optimal medicine for patients with leukemia, optimal genetic test is required depending on indivisual patients. This study was performed by focusing on the detection sensitivity and feasibility to enable genetic test even in the general hospitals. Introduction of the testing method proposed in this study will be expected to contribute to tailor-made medicine.
|